Form 8-K - Current report:
SEC Accession No. 0000950103-22-003581
Filing Date
2022-03-01
Accepted
2022-03-01 08:14:51
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp168191_8k.htm   iXBRL 8-K 23701
2 EXHIBIT 99.1 dp168191_ex9901.htm EX-99.1 133755
6 GRAPHIC image_001.jpg GRAPHIC 2143
  Complete submission text file 0000950103-22-003581.txt   345371

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pgen-20220301.xsd EX-101.SCH 3033
4 XBRL LABEL FILE pgen-20220301_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE pgen-20220301_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT dp168191_8k_htm.xml XML 3477
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 22694091
SIC: 2834 Pharmaceutical Preparations